Stroke Prevention Research
Dr. J. David Spence
&
Dr. Daniel Hackam
Website Designed and Maintained By
Current Research Projects
|
Stroke Prevention & Atherosclerosis Research Centre Current (C) and Recent (R) Studies |
||
|---|---|---|
|
Sponsor
|
Study Name
|
|
|
Peer-Reviewed
|
||
| HSFO* | R | Imaging for appropriate endarterectomy |
| HSFO | R | Linkage studies: London genotyping project |
| HSFO | C | Linkage studies: Chicoutimi phenotyping project |
| HSFO | C | Biomarkers in carotid atherosclerosis |
| HSFO | C | Ultrasound phenotypes and cardiovascular risk |
| CIHR* | C | Canadian Atherosclerosis Imaging Network |
| CIHR | C | Diabetic intervention with vitamins to improve nephropathy (DIVINe) |
| CIHR | C | Thyroxine and carotid plaque progression in subclinical hypothyroidism |
| NIH* | C | Siblings with Ischemic Stroke (SWISS) |
| NIH | R | Vitamin Intervention for Stroke Prevention (VISP) trial |
| NIH | C | Insulin resistance for Ischemic Stroke (IRIS) |
| NIH | C | WARCEF Anticoagulation in patients with low ejection fraction |
|
Contracts
|
||
| Wyeth | R | Policosanol vs. placebo to lower LDL |
| Pfizer | R | TCD Atorvastatin and carotid plaque volume |
| NMT | C | CLOSURE - PFO study |
| Pfizer | R | SPARCL Atorvastatin in stroke patients |
| Sanofi | R | MATCH clopidogrel ± ASA in TIA |
| Pan American | C | DIVINe substudy: carotid plaque progression |
|
Boehringer Ingelheim |
C | PRoFESS placebo controlled study of aggrenox vs. clopidogrel, with & without telmisartan |
| Sanofi | R | CHARISMA ASA ± clopidogrel in stroke prevention |
| Takeda | C | Squalene synthase inhibitor plus rosuvastatin |
|
Glaxo SmithKline |
C | Effect of rosiglitazone on carotid plaque progression |
| Wyeth | C | Immunosuppressives and carotid plaque progression |
| Servier | C | PERFORM terutroban vs ASA in stroke prevention |
| Sanofi-Aventis | C | CRESCENDO rimonabant for insulin resistance |
| Activbiotics | C | Effect of antibiotic therapy for Chlamydia Pneumoniae on carotid atherosclerosis |
|
Internally funded
|
||
| SPARC | R | B12 and carotid plaque |
| SPARC | C | Coenzyme Q10 for statin myopathy |
| SPARC | C | Cutaneous scarring and atherosclerosis |
|
* HSFO is the Heart & Stroke Foundation of Ontario * CIHR is the Canadian Institutes for Health Research * NIH is the National Institutes of Health, USA |
||
© 2008 Stroke Prevention & Atherosclerosis Research Centre (SPARC)